- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07835750
SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision
Comparison of Airway Control Effectiveness of the SafeLM Video Laryngeal Mask and the LMA Classic in Patients Undergoing General Anesthesia for Fibroadenoma Excision
This randomized controlled trial compares the airway management performance of the SafeLM video laryngeal mask with the LMA Classic in adult patients undergoing elective fibroadenoma excision under general anesthesia. Participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic. The primary outcome is oropharyngeal leak pressure. Secondary outcomes include insertion performance, ventilation parameters, hemodynamic responses, and airway-related adverse events.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Interventio / Hoito
Yksityiskohtainen kuvaus
The SafeLM is a video-assisted laryngeal mask that allows visualization during placement, whereas the LMA Classic is a conventional supraglottic airway device. This study is designed to compare the clinical performance of these two devices under standardized conditions.
Adult patients scheduled for elective fibroadenoma excision under general anesthesia will be screened for eligibility. Only patients for whom both devices are considered clinically appropriate will be enrolled, thereby avoiding randomization when patient characteristics indicate a preference for a particular airway management technique. Eligible participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic.
After standardized induction of general anesthesia, the assigned laryngeal mask will be inserted according to the study protocol. The primary outcome is oropharyngeal leak pressure after successful placement. Device insertion characteristics, ventilation parameters, hemodynamic responses, and airway-related adverse events will also be evaluated.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Hung T. Tran, MD
- Puhelinnumero: +84367378519
- Sähköposti: thanhhungvt@gmail.com
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Female patients aged 18 years or older.
- Scheduled for elective excision of benign breast fibroadenoma under general anesthesia.
- Planned airway management with a laryngeal mask airway.
- American Society of Anesthesiologists (ASA) physical status I-II.
- Both the SafeLM and LMA Classic are considered clinically appropriate for airway management.
- Provision of written informed consent.
Exclusion Criteria:
- Increased risk of pulmonary aspiration, including inadequate preoperative fasting, full stomach, or gastrointestinal obstruction.
- Known or suspected difficult airway or other airway characteristics for which random allocation between the two study devices is considered clinically inappropriate.
- Upper airway pathology or anatomical abnormality that may interfere with laryngeal mask placement.
- Clinical or surgical indication requiring tracheal intubation rather than a laryngeal mask airway.
- Contraindication or known allergy to medications used in the standardized anesthesia protocol.
- Inability to provide informed consent.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Muut
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: SafeLM Video Laryngeal Mask
Participants randomized to this arm will receive airway management with the SafeLM video laryngeal mask during general anesthesia for elective fibroadenoma excision. The device will be inserted according to the standardized study protocol. |
The SafeLM is a video-assisted supraglottic airway device that allows visualization of the laryngeal structures during insertion and positioning. It will be used for airway management during general anesthesia according to the standardized study protocol. |
|
Active Comparator: LMA Classic
Participants randomized to this arm will receive airway management with the LMA Classic during general anesthesia for elective fibroadenoma excision. The device will be inserted according to the standardized study protocol. |
The LMA Classic is a conventional supraglottic airway device without video guidance. It will be used for airway management during general anesthesia according to the standardized study protocol. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Oropharyngeal Leak Pressure (OLP)
Aikaikkuna: Immediately after successful laryngeal mask placement, before the start of surgery
|
Oropharyngeal leak pressure will be measured after successful placement of the assigned laryngeal mask and establishment of effective ventilation. OLP will be recorded in cmH2O as the airway pressure at which an audible oropharyngeal leak is detected during a standardized leak test. |
Immediately after successful laryngeal mask placement, before the start of surgery
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
First-attempt insertion success
Aikaikkuna: During initial laryngeal mask insertion
|
Proportion of participants in whom effective ventilation is achieved after the first insertion attempt of the assigned laryngeal mask. |
During initial laryngeal mask insertion
|
|
Overall insertion success
Aikaikkuna: During laryngeal mask insertion, up to 3 attempts
|
Proportion of participants in whom effective ventilation is achieved with the assigned laryngeal mask within the maximum number of insertion attempts permitted by the study protocol. |
During laryngeal mask insertion, up to 3 attempts
|
|
Laryngeal mask insertion time
Aikaikkuna: During laryngeal mask insertion
|
Time in seconds from introduction of the assigned laryngeal mask into the mouth until establishment of effective ventilation. |
During laryngeal mask insertion
|
|
Number of insertion attempts
Aikaikkuna: During laryngeal mask insertion
|
Number of attempts required to achieve successful placement and effective ventilation with the assigned laryngeal mask. |
During laryngeal mask insertion
|
|
Need for additional airway maneuvers
Aikaikkuna: During laryngeal mask insertion
|
Proportion of participants requiring additional maneuvers to achieve satisfactory placement and ventilation. |
During laryngeal mask insertion
|
|
Peak inspiratory pressure
Aikaikkuna: At 5 and 30 minutes after successful laryngeal mask placement
|
Peak inspiratory airway pressure measured in cmH2O during mechanical ventilation. |
At 5 and 30 minutes after successful laryngeal mask placement
|
|
End-tidal carbon dioxide
Aikaikkuna: At 5 and 30 minutes after successful laryngeal mask placement
|
End-tidal carbon dioxide (EtCO2) measured during mechanical ventilation. |
At 5 and 30 minutes after successful laryngeal mask placement
|
|
Heart Rate
Aikaikkuna: At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
Heart rate will be recorded in beats per minute (bpm). |
At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
|
Blood staining on the laryngeal mask
Aikaikkuna: Immediately after device removal
|
Presence of visible blood staining on the laryngeal mask after removal. |
Immediately after device removal
|
|
Postoperative sore throat
Aikaikkuna: At 1 and 24 hours after surgery
|
Presence of patient-reported sore throat following general anesthesia. |
At 1 and 24 hours after surgery
|
|
Postoperative hoarseness
Aikaikkuna: At 1 and 24 hours after surgery
|
Presence of patient-reported hoarseness following general anesthesia. |
At 1 and 24 hours after surgery
|
|
Airway-related adverse events
Aikaikkuna: From laryngeal mask insertion through postoperative observation, assessed up to 24 hours after surgery
|
Occurrence of airway-related adverse events, including laryngospasm and clinically evident regurgitation. |
From laryngeal mask insertion through postoperative observation, assessed up to 24 hours after surgery
|
|
Arterial Pressure
Aikaikkuna: At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
Arterial pressure will be recorded in mmHg. |
At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- HMU-SAFELM-CLASSIC-2026-01
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Yhdysvalloissa valmistettu ja sieltä viety tuote
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .